Article
Triage options for positive high-risk HPV results from HPV-based cervical cancer screening: a review of the potential alternatives to Papanicolaou test cytology.
Journal of the American Society of Cytopathology - 1 Jan 2000
Thrall Michael J, McCarthy Erin, Mito Jeffrey K, Rao Jianyu
Abstract excerpt
The American Cancer Society has recommended high-risk human papillomavirus (HPV) testing as the primary screening method for cervical cancer since 2020. Up to this point, the transition from Pap test cytology-based screening or co-testing with cytology and HPV testing has been slow and limited. However, more health systems in the United States are in the process of implementing this change. The transition to...
Topics
Join the communities discussing this publication.
